The M1 phenotype is activated by Toll-like receptor ligands, and interferon gamma (IFN-γ), produces tumor cytotoxicity by producing pro-inflammatory cytokines such as TNF-α and IL-1β, and inhibits tumor progression. The gene discussed is IL1B; the disease is neoplasm.